ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2249 • 2019 ACR/ARP Annual Meeting

    Evaluation of Rheumatoid Arthritis Patients’ Preferences Using Discrete Choice Experiment

    Aniket Kawatkar1, 1Kaiser Permanente Southern California, Pasadena, CA

    Background/Purpose: Rheumatoid arthritis (RA) exerts multifaceted burden through medical expenditures, productivity losses, disability, and intangible costs of pain, fatigue, and loss of functional capacity. Patient…
  • Abstract Number: 2250 • 2019 ACR/ARP Annual Meeting

    Contribution of Personality Traits, Psychological Factors and Health Related Quality of Life on Medication Adherence in Patients with RA

    Kyung Min Ko1, Su-Jin Moon 2, Jung Hee Koh 1 and Jun-Ki Min 1, 1Division of Rheumatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Bucheon, Republic of Korea, 2Division of Rheumatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Uijeongbu, Republic of Korea

    Background/Purpose: Non-adherence to long-term treatment is important in Rheumatoid arthritis (RA), as it can result in inadequate disease control and make rheumatologist to change the…
  • Abstract Number: 2251 • 2019 ACR/ARP Annual Meeting

    Understanding Vulnerabilities in Diagnosis and Care of Childhood and Adult-Onset Lupus: A Qualitative Study

    Siobhan Case1, Corine Sinnette 2, Courtnie Phillip 2, Claire Grosgogeat 3, Karen Costenbader 2, Cianna Leatherwood 4, Candace Feldman 2 and Mary Beth Son 3, 1Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston Children's Hospital, Boston, MA, 4Kaiser Permanente, San Francisco, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) poses complex diagnostic and management challenges, which may differ depending on whether SLE was diagnosed in childhood (cSLE) or in…
  • Abstract Number: 2252 • 2019 ACR/ARP Annual Meeting

    The #Worldlupusday 2019 Across Twitter: An Explorative Analysis of Spreading Concepts and Sentiment Perceptions on Social Media

    Salvatore Pirri1, Valentina Lorenzoni 2, Leopoldo Trieste 3, Rosaria Talarico 4, Ilaria Palla 3, Chiara Tani 5, Elena Elefante 5, Sara Cannizzo 1, Isotta Triulzi 3, Simone Ticciati 6, Giuseppe Turchetti 3 and Marta Mosca 5, 1Institute of Management, Scuola Superiore Sant'Anna, Pisa, Toscana, Italy, 2Institute of Management , Scuola Superiore Sant'Anna, Pisa, Italy, 3Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy, 4Università di Pisa, Pisa, Italy, 5Rheumatology Unit, Department of clinical and experimental medicine, University of Pisa, Pisa, Italy, 6Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Italy, Pisa, Italy

    Background/Purpose: Social media nowadays has the capacity to disclose sentiments and opinions difficult to obtain elsewhere. This is of valuable importance in the healthcare sector…
  • Abstract Number: 2253 • 2019 ACR/ARP Annual Meeting

    Comparing Patient and Provider Perspectives on Long Term Biologic Use and Tapering in Stable, Well-Controlled Rheumatoid Arthritis

    Patrick Webster1, Nicole Wilson 2, Christina Payne 1, Kelly Shields 3 and Tarun Sharma 1, 1Allegheny Health Network, Pittsburgh, PA, 2Medicine Institute Research, Bioinformatics, Pittsburgh, PA, 3Highmark Data Science, Pittsburgh

    Background/Purpose: The 2015 American College of Rheumatology (ACR) and 2013 European League Against Rheumatology (EULAR) guidelines for management of rheumatoid arthritis (RA) conditionally recommend consideration…
  • Abstract Number: 2254 • 2019 ACR/ARP Annual Meeting

    The Urge for Mobile Apps in Rheumatology – a German Patient Perspective

    Johannes Knitza1, Christina Raab 1, Antonia Lambrecht 1, David Simon 2, Melanie Hagen 1, Sara Bayat 1, Georg Schett 3, Arnd Kleyer 1 and Axel Hueber 4, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 3Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany; Sektion Rheumatologie, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany, Erlangen, Germany

    Background/Purpose: Mobile health applications have the potential of saving costs, empowering patients and improving treatment outcomes. Furthermore, the use of medical apps in routine care…
  • Abstract Number: 2255 • 2019 ACR/ARP Annual Meeting

    Adherence to Subcutaneous Anti-tnf Therapies in Chronic Inflammatory Rheumatism and Therapeutic Education

    Francoise Fayet1, Angelique Fan 1, Malory Rodere 1, CARINE SAVEL 2, Bruno Pereira 1 and Martin SOUBRIER 3, 1CHU Clermont-Ferrand, Clermont-ferrand, France, 2CHU Gabriel Montpied, Clermont-Ferrand, Auvergne, France, 3CHU Gabriel Montpied, Clermont Ferrand, Auvergne, France

    Background/Purpose: The treatment options for chronic inflammatory rheumatism (CIR) have grown over the last few years with the emergence of anti-tumor necrosis factor (anti-TNF) agents.…
  • Abstract Number: 2256 • 2019 ACR/ARP Annual Meeting

    Patient Beliefs and Perceptions of Methotrexate for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis

    W. Benjamin Nowell1, Elaine Karis 2, Kelly Gavigan 1, Laura Stradford 1, Scott Stryker 3, Shilpa Venkatachalam 1, Gregory Kricorian 3 and Jeffrey Curtis 4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2Amgen Inc, Thousand Oaks, CA, 3Amgen Inc., Thousand Oaks, CA, 4University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Methotrexate (MTX) is a frequently used therapy in both Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) due to its beneficial effects in both populations.…
  • Abstract Number: 2257 • 2019 ACR/ARP Annual Meeting

    Patient and Clinical Characteristics Associated with Increased Willingness to Adopt RA Treatment After an Educational Intervention: An Analysis of the Confident Treatment Decisions for Living with Rheumatoid Arthritis (CONTROL-RA) Trial

    Adam Taylor1, Lang Chen 1, Ronan O'Beirne 2, Joshua Melnick 3, Eric Ruderman 4, Jeffrey Curtis 1 and Maria Danila 1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, 3University of Alabama at Birmingham, Birmimgham, AL, 4Northwestern University Feinberg School of Medicine, Division of Rheumatology, Evanston, IL

    Background/Purpose: The treat to target (T2T) treatment strategy is associated with better clinical outcomes in patients with rheumatoid arthritis (RA). We have previously found that…
  • Abstract Number: 2258 • 2019 ACR/ARP Annual Meeting

    Causes of Influenza Vaccine Hesitancy in Rheumatoid Arthritis and Adults with Juvenile Idiopathic Arthritis

    Sandra Pelaez 1, Vincent Gosselin Boucher 2, Valeria Valerio 3, Elizabeth M. Hazel 4, Kim Lavoie 5, Brian Ward 6 and Ines Colmegna6, 1Research Centre of the Sainte-Justine University Hospital, Montreal, Canada, 2Montreal Behavioural Medicine Centre, Centre Intégré Universitaire de santé et services sociaux du Nord-de-l’Ile-de-Montréal (CIUSSS-NIM), Hôpital du Sacré-Cœur de Montréal & Department of Psychology, Université du Québec à Montréal, Montreal, QC, Canada, 3The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4McGill University Health Centre, Montreal, Canada, 5Montreal Behavioural Medicine Centre, Centre Intégré Universitaire de santé et services sociaux du Nord-de-l’Ile-de-Montréal (CIUSSS-NIM), Hôpital du Sacré-Cœur de Montréal & Department of Psychology, Université du Québec à Montréal, Montreal, Canada, 6McGill University Health Center, Montreal, QC, Canada

    Background/Purpose: Vaccine hesitancy -the reluctance or refusal to vaccinate despite the availability of vaccines- is one of the threats to global health set by the…
  • Abstract Number: 2259 • 2019 ACR/ARP Annual Meeting

    Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group

    Jude des Bordes 1, Jessica Foreman 1, Maria Lopez-Olivo1, Susan K Peterson 1, Tiffany Westrich-Robertson 2, Catherine Hofstetter 3, Anne Lyddiatt 4, Amye Leong 5 and Maria E. Suárez-Almazor 6, 1The University of Texas, MD Anderson Cancer Center, Houston, TX, 2International Foundation for Autoimmune and Autoinflammatory Arthritis, Saint Louis, MO, 3Patient advocate, Toronto, ON, Canada, 4Musculoskeletal Group, Cochrane Collaboration, Toronto, ON, Canada, 57. Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Santa Barbara, CA, 6Department of Rheumatology/Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX , USA., Houston, TX

    Background/Purpose: Patients with rheumatoid arthritis (RA) face a number of challenges which adversely affect their quality of life. The objective was to qualitatively evaluate content…
  • Abstract Number: 2260 • 2019 ACR/ARP Annual Meeting

    Patients’ Journeys Through Giant Cell Arteritis: A Qualitative Study

    Jennie Best1, Ivan Nunez 2, Kristina Woodburn 2, Abby Breyer 2, Mike Conway 2 and Margaret Michalska 1, 1Genentech, Inc., South San Francisco, CA, 2Azul Seven, Minneapolis, MN

    Background/Purpose: Diagnosis of giant cell arteritis (GCA) is difficult due to multiple presenting symptoms, and access to care may be delayed because often multiple providers…
  • Abstract Number: 2261 • 2019 ACR/ARP Annual Meeting

    Post Traumatic Stress Disorder in Patients with Rheumatoid Arthritis

    Marisel Vanesa Bejarano1, Anastasia Secco 2, Marta mamani 2, Felix Romanini 2 and Natalia Tamborenea 3, 1Hospital Bernardino Rivadavia, Caba, Buenos Aires, Argentina, 2Hospital Rivadavia, Caba, Buenos Aires, Argentina, 3Hospital Rivadavia, Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: There is growing evidence that complex interactions between individual's genetic susceptibility, immunological processes, and environmental factors such as stress , increase the risk of…
  • Abstract Number: 2262 • 2019 ACR/ARP Annual Meeting

    Evaluation of Illness Perception in Systemic Sclerosis Patients with Pulmonary Involvement

    Bruna Giusto Bunjes1, Percival Degrava Sampaio-Barros 2 and Ana Paula Luppino-Assad 3, 11- Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Sao Paulo, Brazil, 2Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Brazil, Sao Paulo, Brazil, 3Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Sao Paulo, Brazil

    Background/Purpose: Lung disease is the current leading cause of death and the most common severe complication of systemic sclerosis (SSc), causing a significant adverse impact in quality of…
  • Abstract Number: 2263 • 2019 ACR/ARP Annual Meeting

    A Qualitative Study Evaluating Near-Patient Tools Including a Mobile Application for Earlier RA Referral; Potential to Reduce Chronic Disease Burden

    Norma Biln 1, Simran Chahal1, Bruce Clarke 2 and Alison Warner 2, 1Augurex Life Sciences Corp, Vancouver, Canada, 2B2 Consulting, Kelowna, Canada

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, debilitative autoimmune disease. Patients who are treated with disease modifying therapy within 6-12 weeks of symptom onset have…
  • « Previous Page
  • 1
  • …
  • 1088
  • 1089
  • 1090
  • 1091
  • 1092
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology